Dietary Monosaccharide Supplementation in Patients With Congenital Disorders of Glycosylation

NCT04198987 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2025-10-01

No results posted yet for this study

Summary

Researchers are trying to assess whether the use of simple sugars given as a daily dietary supplement can improve the health of children with congenital disorders of glycosylation (CDG).

Conditions

  • Congenital Disorder of Glycosylation

Sponsors & Collaborators

Principal Investigators

  • David Deyle, MD · Mayo Clinic

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-06
Primary Completion
2025-06-11
Completion
2025-06-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04198987 on ClinicalTrials.gov